Bloomberg

Page 9 of 100

Hong Kong’s latest bubble tea IPO mints another billionaire
Finance

Hong Kong’s latest bubble tea IPO mints another billionaire

By Filipe Pacheco, Diana Li and Bloomberg
February 12, 2025
CATL files for Hong Kong listing that could raise $5 billion
Tech

CATL files for Hong Kong listing that could raise $5 billion

By Foster Wong and Bloomberg
February 12, 2025
Philippine lawmakers plan to approve bill to ban ore exports
Tech

Philippine lawmakers plan to approve bill to ban ore exports

By Cliff Venzon, Neil Jerome Morales and Bloomberg
February 7, 2025
New Zealand hints at letting more foreign investors buy homes
Finance

New Zealand hints at letting more foreign investors buy homes

By Tracy Withers and Bloomberg
February 7, 2025
China’s 60-second dramas head to the U.S. after beating box office
Tech

China’s 60-second dramas head to the U.S. after beating box office

By Sohee Kim and Bloomberg
February 6, 2025
Honda-Nissan deal thrown into doubt only weeks after talks began
Finance

Honda-Nissan deal thrown into doubt only weeks after talks began

By Nicholas Takahashi and Bloomberg
February 5, 2025
Thailand cuts power supply to Myanmar in blow to scam centers
Politics

Thailand cuts power supply to Myanmar in blow to scam centers

By Patpicha Tanakasempipat and Bloomberg
February 5, 2025
Trump plans to speak with Xi as deadline for China tariffs looms
Politics

Trump plans to speak with Xi as deadline for China tariffs looms

By Jasmine Ng and Bloomberg
February 4, 2025
Chinese tourists avoid far-flung trips over lunar holiday
Lifestyle

Chinese tourists avoid far-flung trips over lunar holiday

By
January 24, 2025
SK Hynix’s stock dips after profit misses lofty expectations
Tech

SK Hynix’s stock dips after profit misses lofty expectations

By Yoolim Lee and Bloomberg
January 23, 2025
India set to take back 18,000 citizens from U.S. to placate Trump
Politics

India set to take back 18,000 citizens from U.S. to placate Trump

By Sudhi Ranjan Sen, Dan Strumpf and Bloomberg
January 22, 2025
Eli Lilly & Co., the Coins2Day 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
Panama opens audit of Chinese port operator while Trump threatens to take canal back
Politics

Panama opens audit of Chinese port operator while Trump threatens to take canal back

By Michael McDonald, Shirley Zhao and Bloomberg
January 21, 2025
Tencent stake in Skydance-Paramount draws lawmaker scrutiny
Tech

Tencent stake in Skydance-Paramount draws lawmaker scrutiny

By Kelcee Griffis and Bloomberg
January 16, 2025
BYD wants to win over South Korea with $21,600 electric car
Tech

BYD wants to win over South Korea with $21,600 electric car

By Heejin Kim and Bloomberg
January 16, 2025

Most Popular